PAR Insider Sale: CFO Menar Exercises Options, Sells 6,500 Shares Under 10b5-1 Plan
Rhea-AI Filing Summary
PAR Technology Corp. insider transactions by CFO Bryan A. Menar on 09/10/2025
Bryan Menar, Chief Financial Officer, executed a scheduled set of transactions under a Rule 10b5-1 plan on September 10, 2025. He exercised 6,500 employee stock options at an $8.82 exercise price and simultaneously sold 6,500 shares at a weighted-average price of $46.06, reducing his direct common stock holdings from 77,981 to 71,481 shares. The sale prices ranged from $45.31 to $47.56. The underlying option is part of a larger grant exercisable in installments and expires December 8, 2027.
Positive
- Transaction executed under a Rule 10b5-1 trading plan, which provides an affirmative defense and suggests pre-planned liquidity rather than opportunistic trading.
- Clear disclosure of exercise and sale prices, including weighted-average sale price range ($45.31–$47.56), supporting transparency.
Negative
- Reduction in direct ownership from 77,981 to 71,481 shares, representing decreased insider stake.
- Large realized gain (exercise at $8.82 vs sale at $46.06 weighted average) may attract investor attention regarding insider liquidity.
Insights
TL;DR: CFO exercised options and sold the same number of shares under a pre-established 10b5-1 plan, realizing substantial per-share gains.
The filing shows a routine, pre-planned liquidity event rather than an ad hoc insider sale. Exercising options at $8.82 and selling at a weighted average of $46.06 implies a material per-share spread, crystallizing gains for the reporting person. Because the sale was conducted pursuant to a 10b5-1 plan adopted March 10, 2025, the transactions carry the affirmative-defense structure against insider trading allegations, reducing legal/regulatory risk. Ownership decreased modestly but the filing does not indicate any change in executive role or company fundamentals.
TL;DR: Transaction appears procedurally compliant and nonmaterial to control, but it does reduce the officer's direct stake.
The disclosure includes required explanatory footnotes and attorney-in-fact signature, indicating compliance with Form 4 mechanics. The transaction reduced direct holdings by 6,500 shares, a modest change relative to total reported holdings. The existence of a multi-installment option grant and use of a 10b5-1 plan align with common governance practices for planned insider liquidity. No indications of abnormal timing or unusual derivative activity are present in this filing.
FAQ
What did PAR CFO Bryan Menar do on 09/10/2025?
Was the sale by the PAR CFO pre-planned or ad hoc?
How did the transactions affect Bryan Menar's holdings in PAR?
What price range were the shares sold at?
Are there any derivative holdings remaining after the transaction?